Relationship between Symptoms and Health-Related Quality of Life in Patients Treated for Hypertension

Pharmacotherapy

Volumn 24, Issue 3, 2004, Pages 344-350

  Erickson, Steven R ^a   Williams, Brent C ^b   Gruppen, Larry D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Hypertension; Quality of life; Symptoms

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; MINOXIDIL;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; DEMOGRAPHY; DISEASE DURATION; DIZZINESS; EDUCATION; FATIGUE; FEMALE; HEALTH SURVEY; HEARTBURN; HUMAN; HYPERTENSION; INCOME; LETHARGY; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SUMMARY; MULTIVARIATE ANALYSIS; NOCTURIA; OUTPATIENT CARE; PHYSICAL COMPONENT SUMMARY; POLYPHARMACY; PREDICTION; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEX; SHORT FORM 36; SYMPTOMATOLOGY; UNIVERSITY HOSPITAL; XEROSTOMIA;

AGED; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; MALE; MICHIGAN; MIDDLE AGED; ODDS RATIO; QUALITY OF LIFE; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 1542316368     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.4.344.33177     Document Type: Article

References (40)

1. Kullman S, Svardsudd K. Differences in perceived symptoms/quality of life in untreated hypertensive and normotensive men. Scand J Prim Health Care 1990;8(suppl 1):47-53.
2. Battersby C, Hartley K, Fletcher AE, et al. Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens 1995;9:981-6.
3. Puller A, Montoya P, Schandry R, Hartl L. Changes in physical symptoms, blood pressure and quality of life over 30 days. Behav Res 1994;32:593-603.
4. Schoenberger JA, Croog SH, Sudilovky A, Levine S, Baume RM. Self-reported side effects from antihypertensive drugs: a clinical trial. Am J Hypertens 1990;3:123-32.
5. Siegrist J, Matschinger H, Motz W. Untreated hypertensives and their quality of life. J Hypertens 1987;5(suppl 1):S15-20.
6. Kjellgren KI, Ahlner J, Dahlof B, Gill H, Hedner T, Saljo R. Perceived symptoms amongst hypertensive patients in routine clinical practice: a population-based study. J Intern Med 1998;244:325-32.
7. Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman N. Antihypertensive drug side effects in the hypertension detection and follow-up program. Hypertension 1988;11(suppl 11):51-5.
8. Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Human Hypertens 2001;15:539-48.
9. Guyatt GH, Feeny DH, Patrick DKL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
10. Fitzpatrick R, Fletcher A, Gore S, Jones D, Speigelhalter D, Cox D. Quality of life measures in health care: applications and issues in assessment. Br Med J 1992;305:1074-7.
11. Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin dependent diabetes mellitus. Med Care 1994;32:1173-81.
12. Beto JA, Bansal VK. Quality of life in treatment of hypertension: a meta-analysis of clinical trials. Am J Hyperten 1992;5:125-33.
13. Wilson IR, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:59-65.
14. Anderson RB, Testa MA. Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Information J 1994;28:89-114.
15. Anderson RB, Nackley JF, Testa MA. Symptom distress check lists as a component of quality of life measurement; comparing symptom reports with responses to multiple choice questionnaires. Drug Information J 1995;29:1689-707S.
16. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens 1991;4:363-73.
17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
18. Lawrence WF, Fryback DG, Martin PA, Klein R, Klein BEK. Health status and hypertension: a population-based study. J Clin Epidemiol 1996;49:1239-45.
19. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the medical outcomes study. JAMA 1989;262:907-13.
20. Hollenberg NK, Williams GH, Anderson R. Medical therapy, symptoms, and the distress they cause. Arch Intern Med 2000;160:1477-83.
21. Anderson RT, Hogan P, Apel L, Rosen R, Shumaker SA. Baseline correlates with quality of life among men and women with medication-controlled hypertension. The trial of nonpharmacologic interventions in the elderly (TONE). J Am Geriatr Soc 1997;45:1080-5.
22. Bulpitt CJ, Dollery CT, Carne S, Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976;38:121-8.
23. Weiss NS. Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The United States health examination survey of adults. N Engl J Med 1972;287:632-3.
24. Bansal S. Sexual dysfunction in hypertensive men: a critical review of the literature. Hypertension 1988;12:1-10.
25. Shapiro AP, Miller RE, King HE, Ginchereau EH, Fitzgibbon K. Behavioral consequences of mild hypertension. Hypertension 1982;4:355-60.
26. VanderPloeg RD, Goldman H, Kleinman KM. Relationship between systolic and diastolic blood pressure and cognitive functioning in hypertensive subjects: an extension of previous findings. Arch Clin Neuropsychol 1987;2:101-9.
27. Medical Research Council Working Party. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension: report of Medical Research Council Working Party on mild to moderate hypertension. Lancet 1981;2:539-43.
28. Bulpitt CJ, Fletcher AE. Quality of life in hypertensive patients on different antihypertensive treatment: rationale for methods employed in a multicenter randomized controlled trial. J Cardiovasc Pharmacol 1985;7:S137-45.
29. Toyoshima H, Takahashi K, Akera T. The impact of side effects on hypertension management: a Japanese survey. Clin Thera 1997;19:1458-69.
30. Bardage C, Isacson DGL. Self-reported side-effects of antihypertensive drugs: an epidemiological study on prevalence and impact on health-state utility. Blood Pressure 2000;9:328-34.
31. Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W. Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 1985;253:3263-8.
32. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657-64.
33. Croog SH, Sudilovsky A, Levine S, Testa MA. Work performance, absenteeism, and antihypertensive medications. J Hypertens 1987;5(suppl):S47-54.
34. Bardage C, Isacson DGL. Hypertension and health-related quality of life: an epidemiological study in Sweden. J Clin Epidemiol 2001;54:172-81.
35. Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life? J Human Hypertension 2001;15(suppl 1):S65-8.
36. Leventhal H, Diefenbach M, Leventhal EA. Illness cognitions: using common-sense to understand treatment adherence and affect cognition interactions. Cognitive Ther Res 1992;16:143-63.
37. Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociol Health Illn 1988;10:561-78.
38. Baumann LJ, Leventhal H. "I can tell when my blood pressure is up, can't I?" Health Psychol 1985;4:203-18.
39. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosomatic Res 1999;47:555-67.
40. Fincke BG, Miller DR, Spiro, A. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med 1998;13:182-5.